Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, SANARA MEDTECH INC. reported revenue of $103M, up 19.0% year over year. Operating margin was 7.1% and net margin -36.4%, on a free-cash-flow margin of 2.1% with capital expenditure at 4.5% of revenue. Every figure is computed directly from SMTI's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $103M | 7.1% | -36.4% |
| FY2024 | $87M | 1.5% | -11.2% |
| FY2023 | $65M | -6.5% | -6.6% |
| FY2022 | $46M | -27.3% | -17.3% |
| FY2021 | $24M | -30.6% | -32.8% |
How does SMTI compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.